Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Lyudmila G. Burdelya,1*
Vadim I. Krivokrysenko,2*
Thomas C. Tallant,3
Evguenia Strom,2
Anatoly S. Gleiberman,2
Damodar Gupta,1
Oleg V. Kurnasov,4
Farrel L. Fort,2
Andrei L. Osterman,4
Joseph A. DiDonato,3
Elena Feinstein,2
Andrei V. Gudkov1,2
Abstract:
The toxicity of ionizing radiation is associated with massiveapoptosis in radiosensitive organs. Here, we investigate whethera drug that activates a signaling mechanism used by tumor cellsto suppress apoptosis can protect healthy cells from the harmfuleffects of radiation. We studied CBLB502, a polypeptide drugderived from Salmonella flagellin that binds to Toll-like receptor5 (TLR5) and activates nuclear factor–B signaling. A singleinjection of CBLB502 before lethal total-body irradiation protectedmice from both gastrointestinal and hematopoietic acute radiationsyndromes and resulted in improved survival. CBLB502 injectedafter irradiation also enhanced survival, but at lower radiationdoses. It is noteworthy that the drug did not decrease tumorradiosensitivity in mouse models. CBLB502 also showed radioprotectiveactivity in lethally irradiated rhesus monkeys. Thus, TLR5 agonistscould potentially improve the therapeutic index of cancer radiotherapyand serve as biological protectants in radiation emergencies.
1 Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. 2 Cleveland BioLabs, Inc. (CBLI), Buffalo, NY14203, USA. 3 Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. 4 Burnham Institute for Medical Research, La Jolla, CA 92037, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: andrei.gudkov{at}roswellpark.org; efeinstein{at}cbiolabs.com
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (15 April 2008) Sci. Signal.1 (15), ec135.
[DOI: 10.1126/stke.115ec135] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
L. G. Burdelya, C. M. Brackett, B. Kojouharov, I. I. Gitlin, K. I. Leonova, A. S. Gleiberman, S. Aygun-Sunar, J. Veith, C. Johnson, G. J. Haderski, et al. (2013)
PNAS
110, E1857-E1866
|Abstract »|Full Text »|PDF »
A Multifunctional Chimeric Chaperone Serves as a Novel Immune Modulator Inducing Therapeutic Antitumor Immunity.
X. Yu, C. Guo, H. Yi, J. Qian, P. B. Fisher, J. R. Subjeck, and X.-Y. Wang (2013)
Cancer Res.
73, 2093-2103
|Abstract »|Full Text »|PDF »
Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist.
Z. Hu, Y. Xing, Y. Qian, X. Chen, J. Tu, L. Ren, K. Wang, and Z. Chen (2013)
J Radiat Res
54, 243-250
|Abstract »|Full Text »|PDF »
Sodium orthovanadate (vanadate), a potent mitigator of radiation-induced damage to the hematopoietic system in mice.
B. Wang, K. Tanaka, A. Morita, Y. Ninomiya, K. Maruyama, K. Fujita, Y. Hosoi, and M. Nenoi (2013)
J Radiat Res
|Abstract »|Full Text »|PDF »
Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.
D. W. Thorpe, A. M. Stringer, and R. J. Gibson (2013)
Exp Biol Med
238, 1-6
|Abstract »|Full Text »|PDF »
Systemic Flagellin Immunization Stimulates Mucosal CD103+ Dendritic Cells and Drives Foxp3+ Regulatory T Cell and IgA Responses in the Mesenteric Lymph Node.
A. Flores-Langarica, J. L. Marshall, J. Hitchcock, C. Cook, J. Jobanputra, S. Bobat, E. A. Ross, R. E. Coughlan, I. R. Henderson, S. Uematsu, et al. (2012)
J. Immunol.
189, 5745-5754
|Abstract »|Full Text »|PDF »
A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease.
X. Ding, G. Bian, N. D. Leigh, J. Qiu, P. L. McCarthy, H. Liu, S. Aygun-Sunar, L. G. Burdelya, A. V. Gudkov, and X. Cao (2012)
J. Immunol.
189, 4719-4727
|Abstract »|Full Text »|PDF »
Identification of Granulocyte Colony-Stimulating Factor and Interleukin-6 as Candidate Biomarkers of CBLB502 Efficacy as a Medical Radiation Countermeasure.
V. I. Krivokrysenko, A. N. Shakhov, V. K. Singh, F. Bone, Y. Kononov, I. Shyshynova, A. Cheney, R. K. Maitra, A. Purmal, M. H. Whitnall, et al. (2012)
J. Pharmacol. Exp. Ther.
343, 497-508
|Abstract »|Full Text »|PDF »
Core circadian protein CLOCK is a positive regulator of NF-{kappa}B-mediated transcription.
M. L. Spengler, K. K. Kuropatwinski, M. Comas, A. V. Gasparian, N. Fedtsova, A. S. Gleiberman, I. I. Gitlin, N. M. Artemicheva, K. A. Deluca, A. V. Gudkov, et al. (2012)
PNAS
109, E2457-E2465
|Abstract »|Full Text »|PDF »
Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.
M. A. Ciorba, T. E. Riehl, M. S. Rao, C. Moon, X. Ee, G. M. Nava, M. R. Walker, J. M. Marinshaw, T. S. Stappenbeck, and W. F. Stenson (2012)
Gut
61, 829-838
|Abstract »|Full Text »|PDF »
Radiation damage and radioprotectants: new concepts in the era of molecular medicine.
Structural Basis of TLR5-Flagellin Recognition and Signaling.
S.-i. Yoon, O. Kurnasov, V. Natarajan, M. Hong, A. V. Gudkov, A. L. Osterman, and I. A. Wilson (2012)
Science
335, 859-864
|Abstract »|Full Text »|PDF »
Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism.
T. E. Riehl, L. Foster, and W. F. Stenson (2012)
Am J Physiol Gastrointest Liver Physiol
302, G309-G316
|Abstract »|Full Text »|PDF »
Bactericidal/Permeability-Increasing Protein (rBPI21) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death.
E. C. Guinan, C. M. Barbon, L. A. Kalish, K. Parmar, J. Kutok, C. J. Mancuso, L. Stoler-Barak, E. E. Suter, J. D. Russell, C. D. Palmer, et al. (2011)
Science Translational Medicine
3, 110ra118
|Abstract »|Full Text »|PDF »
Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity.
M. S. Hossain, D. L. Jaye, B. P. Pollack, A. B. Farris, M. L. Tselanyane, E. David, J. D. Roback, A. T. Gewirtz, and E. K. Waller (2011)
J. Immunol.
187, 5130-5140
|Abstract »|Full Text »|PDF »
A TLR5 Agonist Inhibits Acute Renal Ischemic Failure.
N. Fukuzawa, M. Petro, W. M. Baldwin III, A. V. Gudkov, and R. L. Fairchild (2011)
J. Immunol.
187, 3831-3839
|Abstract »|Full Text »|PDF »
Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity.
R. M. Jones, V. M. Sloane, H. Wu, L. Luo, A. Kumar, M. V. Kumar, A. T. Gewirtz, and A. S. Neish (2011)
Gut
60, 648-657
|Abstract »|Full Text »|PDF »
Inflammation and p53: A Tale of Two Stresses.
A. V. Gudkov, K. V. Gurova, and E. A. Komarova (2011)
Genes & Cancer
2, 503-516
|Abstract »|Full Text »|PDF »
I. Jarchum, M. Liu, L. Lipuma, and E. G. Pamer (2011)
Infect. Immun.
79, 1498-1503
|Abstract »|Full Text »|PDF »
Sphingosine-1-Phosphate Activates the AKT Pathway to Protect Small Intestines from Radiation-Induced Endothelial Apoptosis.
S. Bonnaud, C. Niaudet, F. Legoux, I. Corre, G. Delpon, X. Saulquin, Z. Fuks, M.-H. Gaugler, R. Kolesnick, and F. Paris (2010)
Cancer Res.
70, 9905-9915
|Abstract »|Full Text »|PDF »
TRIF Mediates Toll-like Receptor 5-induced Signaling in Intestinal Epithelial Cells.
Y. J. Choi, E. Im, H. K. Chung, C. Pothoulakis, and S. H. Rhee (2010)
J. Biol. Chem.
285, 37570-37578
|Abstract »|Full Text »|PDF »
Immediate and Short-, Mid- and Long-term Effects of In Vivo Ionizing Radiation Exposure in BALB/c Mice: I. Activation of Lymphocytes and Subpopulations.
J. HERNANDEZ-GODOY, D. P. SILVESTRE, and B. B. HERNANDEZ (2010)
In Vivo
24, 719-726
|Abstract »|Full Text »|PDF »
TLR5 Signaling Stimulates the Innate Production of IL-17 and IL-22 by CD3negCD127+ Immune Cells in Spleen and Mucosa.
L. Van Maele, C. Carnoy, D. Cayet, P. Songhet, L. Dumoutier, I. Ferrero, L. Janot, F. Erard, J. Bertout, H. Leger, et al. (2010)
J. Immunol.
185, 1177-1185
|Abstract »|Full Text »|PDF »
TRIF Modulates TLR5-dependent Responses by Inducing Proteolytic Degradation of TLR5.
Y. J. Choi, E. Im, C. Pothoulakis, and S. H. Rhee (2010)
J. Biol. Chem.
285, 21382-21390
|Abstract »|Full Text »|PDF »
Reconstitution of a Functional Toll-like Receptor 5 Binding Site in Campylobacter jejuni Flagellin.
M. R. de Zoete, A. M. Keestra, J. A. Wagenaar, and J. P. M. van Putten (2010)
J. Biol. Chem.
285, 12149-12158
|Abstract »|Full Text »|PDF »
Disruption of NF-{kappa}B signalling by ancient microbial molecules: novel therapies of the future?.
M. A. Kinnebrew, C. Ubeda, L. A. Zenewicz, N. Smith, R. A. Flavell, and E. G. Pamer (2010)
The Journal of Infectious Disease
201, 534-543
|Abstract »|Full Text »|PDF »
p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis.
D. G. Kirsch, P. M. Santiago, E. di Tomaso, J. M. Sullivan, W.-S. Hou, T. Dayton, L. B. Jeffords, P. Sodha, K. L. Mercer, R. Cohen, et al. (2010)
Science
327, 593-596
|Abstract »|Full Text »|PDF »
A. Morita, S. Yamamoto, B. Wang, K. Tanaka, N. Suzuki, S. Aoki, A. Ito, T. Nanao, S. Ohya, M. Yoshino, et al. (2010)
Cancer Res.
70, 257-265
|Abstract »|Full Text »|PDF »
High-Throughput Screening Identifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones.
K. Kim, J. M. Pollard, A. J. Norris, J. T. McDonald, Y. Sun, E. Micewicz, K. Pettijohn, R. Damoiseaux, K. S. Iwamoto, J. W. Sayre, et al. (2009)
Clin. Cancer Res.
15, 7238-7245
|Abstract »|Full Text »|PDF »
Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses.
Y.-C. Chang, W.-C. Kao, W.-Y. Wang, W.-Y. Wang, R.-B. Yang, and K. Peck (2009)
FASEB J
23, 3078-3088
|Abstract »|Full Text »|PDF »
Nuclear factor {kappa}B inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos.
B. Daroczi, G. Kari, Q. Ren, A. P. Dicker, and U. Rodeck (2009)
Mol. Cancer Ther.
8, 2625-2634
|Abstract »|Full Text »|PDF »
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer.
L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle (2009)
Pharmacol. Rev.
61, 177-197
|Abstract »|Full Text »|PDF »